179 related articles for article (PubMed ID: 12798521)
1. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII.
Bouwmeester FW; Jonkhoff AR; Verheijen RH; van Geijn HP
Obstet Gynecol; 2003 Jun; 101(6):1174-6. PubMed ID: 12798521
[TBL] [Abstract][Full Text] [Related]
2. [Successful treatment of severe post-partum bleeding after caesarean section using recombinant activated factor VII].
Holub Z; Feyereisl J; Kabelík L; Rittstein T
Ceska Gynekol; 2005 Mar; 70(2):144, 146-8. PubMed ID: 15918270
[TBL] [Abstract][Full Text] [Related]
3. [The use of recombinant factor VIIa on the therapy of massive bleeding after cesarean section].
Uharcek P; Mlyncek M; Kellner M; Lajtman E
Ceska Gynekol; 2007 May; 72(3):200-2. PubMed ID: 17616074
[TBL] [Abstract][Full Text] [Related]
4. [Recombinant activated factor VII as a life-saving therapy for severe postpartum haemorrhage unresponsive to conservative traditional management].
Brice A; Hilbert U; Roger-Christoph S; Fernandez H; Dumenil AS; Descorps-Declère A; Mercier F; Benhamou D
Ann Fr Anesth Reanim; 2004 Nov; 23(11):1084-8. PubMed ID: 15581725
[TBL] [Abstract][Full Text] [Related]
5. Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta.
Mechsner S; Baessler K; Brunne B; Albrecht T; Hopp H; Dudenhausen JW
Fertil Steril; 2008 Nov; 90(5):2012.e1-5. PubMed ID: 18462726
[TBL] [Abstract][Full Text] [Related]
6. [Recombinant factor VIIa for treatment of postpartum hemorrhage due to uterine atony].
Michalska-Krzanowska G
Ginekol Pol; 2010 Jul; 81(7):544-8. PubMed ID: 20825059
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII.
Heilmann L; Wild C; Hojnacki B; Pollow K
Clin Appl Thromb Hemost; 2006 Apr; 12(2):227-9. PubMed ID: 16708127
[TBL] [Abstract][Full Text] [Related]
8. Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period.
Tanchev S; Platikanov V; Karadimov D
Acta Obstet Gynecol Scand; 2005 Apr; 84(4):402-3. PubMed ID: 15762974
[No Abstract] [Full Text] [Related]
9. Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study.
Huber AW; Raio L; Alberio L; Ghezzi F; Surbek DV
J Perinat Med; 2011 Oct; 40(1):43-9. PubMed ID: 22017328
[TBL] [Abstract][Full Text] [Related]
10. [Life-threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven use].
Courtois L; Becher P; Miot S; Maisonnette-Escot Y; Sautière JL; Berthier F; Samain E; Maillet R; Riethmuller D
J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):78-82. PubMed ID: 17293258
[TBL] [Abstract][Full Text] [Related]
11. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.
Verre M; Bossio F; Mammone A; Piccirillo M; Tancioni F; Varano M
Minerva Ginecol; 2006 Feb; 58(1):81-4. PubMed ID: 16498374
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
[TBL] [Abstract][Full Text] [Related]
13. The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience.
Wissa I; Ebeid E; El-Shawarby S; Chandakas S; Kamal T; Hill N
J Obstet Gynaecol; 2009 Jan; 29(1):21-4. PubMed ID: 19280490
[TBL] [Abstract][Full Text] [Related]
14. Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage.
Nohira T; Osakabe Y; Suda S; Takahashi C; Tanaka A; Ikeda K; Ikeda T; Okabe K
J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):623-30. PubMed ID: 18840167
[TBL] [Abstract][Full Text] [Related]
15. Acquired hemophilia as a cause of primary postpartum hemorrhage.
Borna S; Hantoushzadeh S
Arch Iran Med; 2007 Jan; 10(1):107-10. PubMed ID: 17198466
[TBL] [Abstract][Full Text] [Related]
16. [Our experince with the use of recombinant activated factor VII in postpartum haemorrhage].
Mostić T; Sparić R; Argirović R; Ljubić A; Bozanović T; Arsenijević L; Tomanović-Koković J; Stefanović A
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():204-9. PubMed ID: 19562869
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant activated factor VII in massive postpartum haemorrhage.
Bouma LS; Bolte AC; van Geijn HP
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):172-7. PubMed ID: 17928129
[TBL] [Abstract][Full Text] [Related]
18. Recombinant factor VIIa in massive postpartum haemorrhage.
Karalapillai D; Popham P
Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
[TBL] [Abstract][Full Text] [Related]
19. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).
Segal S; Shemesh IY; Blumenthal R; Yoffe B; Laufer N; Ezra Y; Levy I; Mazor M; Martinowitz U
Arch Gynecol Obstet; 2003 Oct; 268(4):266-7. PubMed ID: 14504866
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM
Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
